Bishop, Kevin W. http://orcid.org/0000-0001-8722-6464
Erion Barner, Lindsey A.
Han, Qinghua
Baraznenok, Elena
Lan, Lydia
Poudel, Chetan
Gao, Gan
Serafin, Robert B.
Chow, Sarah S. L. http://orcid.org/0009-0005-7519-9346
Glaser, Adam K.
Janowczyk, Andrew
Brenes, David http://orcid.org/0000-0003-1969-5386
Huang, Hongyi
Miyasato, Dominie
True, Lawrence D.
Kang, Soyoung http://orcid.org/0000-0002-1022-9648
Vaughan, Joshua C. http://orcid.org/0000-0002-6550-8935
Liu, Jonathan T. C. http://orcid.org/0000-0001-5650-3086
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01EB031002, R01CA268207, U54DK137328, R00CA240681, 1R01LM013864, 1U01DK133090, U01CA248226, 2R01DK118431, P50CA097186, U54DK137328)
U.S. Department of Health & Human Services | National Institutes of Health
National Science Foundation (1934292 HDR: I-DIRSE-FW, DGE-1762114, DGE-1762114)
U.S. Department of Defense (W81XWH-18-10358, W81XWH-18-10358)
Prostate Cancer UK (MA-ETNA19-005)
U.S. Department of Health & Human Services | National Institutes of Health
Washington Research Foundation
Chetan Poudel is a Washington Research Foundation Postdoctoral Fellow.
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 27 July 2023
Accepted: 23 October 2023
First Online: 23 January 2024
Competing interests
: J.T.C.L. is a cofounder, equity holder and board member of Alpenglow Biosciences, Inc. A.K.G. and L.D.T. are cofounders and equity holders of Alpenglow Biosciences, Inc. A.J. provides consulting for Merck, Lunaphore and Roche and has a sponsored research agreement with Roche. The remaining authors declare no competing interests.